In this engaging MIA webinar dermatologist A/Prof Linda Martin will guide healthcare professionals through melanoma risk, the use of risk prediction tools, and how to determine appropriate skin assessment, surveillance and specialist referral.
The Partnership Project funding scheme provides funding and support to create new opportunities for researchers and policy makers to work together to define research questions, undertake research, interpret the findings and implement the findings into policy and practice. Partnership Projects [...]
The Melanoma and Skin Cancer Trials 2026 Scientific Meeting will bring together Australian leaders in melanoma and skin cancer clinical trials to share the latest discoveries and foster further innovative research. More details coming soon. Location: Sofitel Melbourne on Collins, Melbourne, [...]
The Australasian Melanoma Conference 2026 is a premier event for professionals involved in melanoma and skin cancer research, diagnosis, and clinical management. The conference will present new discoveries from basic science and explore cutting-edge paradigms in melanoma and skin cancer [...]
Upcoming annual appointments for worldwide cancer clinicians and researchers, gaining more and more attendees every year, the 11th edition of Immunotherapy Bridge and the 16th edition of Melanoma Bridge will be held in Naples (Italy) from November 30th to December 1st and from December 1st to 3rd, [...]
The ASI 2026 Local Organising Committee warmly invites you to join us for the 54th Annual Scientific Meeting of the Australian and New Zealand Society for Immunology (ASI), to be held 30 November – 4 December 2026 in Canberra (Ngunnawal [...]
JOIN US IN THE FIGHT TO CURE CANCER! This meeting brings together a critical mass of national and international leaders in multi-omics, offering: - Cutting-edge science and real-world datasets - Platform launches and hands-on technical workshops - Engagement with leading [...]
The CRI IGNITE Award — Inspiring Growth and Nurturing Independence Through Excellence — supports the transition of outstanding postdoctoral researchers into independent tenure-track investigators. The program offers two sequential phases of funding: Phase 1: Foundation Phase – Up to 2 [...]
The CRI Lloyd J. Old STAR Program — Scientists TAking Risks — provides long-term, flexible funding to mid-career scientists, giving them the freedom to pursue high-risk, high-reward research at the leading edge of cancer immunotherapy. The ideal candidate is a [...]
More information will be available soon. Location: Boston Marriott Copley Place, Boston, Massachusetts, USA Key Dates: Abstract Submission and Congress Registration Opens: 9 September 2026 Abstract Submission Deadline: 9 November 2026 Early Bird Registration Deadline: 22 December 2026 Regular Registration Deadline: [...]
More details coming soon. Location: Vancouver Convention Centre, Vancouver, Canada Key Dates: Meeting dates: 13-18 March 2027 FIND OUT MORE
The #SSO2027 Annual Meeting will take place March 18-20, 2027, in Washington, DC. This year's program will feature new educational sessions, disease site-specific content, dedicated programming for advanced practice providers, residents, and fellows, friendly competition, and expanded networking opportunities. Location: Walter [...]